StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2021, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 23 Jul 2021 16:10:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Form 6-K Auris Medical Holding For: Jul 22 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Auris+Medical+Holding+++++For%3A+Jul+22/18715213.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Auris+Medical+Holding+++++For%3A+Jul+22/18715213.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Auris+Medical+Holding+++++For%3A+Jul+22/18715213.html Fri, 23 Jul 2021 16:10:00 -0400 EARS Form 6-K Auris Medical Holding For: Jul 21 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Auris+Medical+Holding+++++For%3A+Jul+21/18701857.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Auris+Medical+Holding+++++For%3A+Jul+21/18701857.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Auris+Medical+Holding+++++For%3A+Jul+21/18701857.html Wed, 21 Jul 2021 08:02:00 -0400 EARS Auris Medical Announces Launch of New Corporate Website http://www.streetinsider.com/Press+Releases/Auris+Medical+Announces+Launch+of+New+Corporate+Website/18686243.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Auris+Medical+Announces+Launch+of+New+Corporate+Website/18686243.html for the full story. http://www.streetinsider.com/Press+Releases/Auris+Medical+Announces+Launch+of+New+Corporate+Website/18686243.html Fri, 16 Jul 2021 09:00:00 -0400 EARS Auris Medical Announces Launch of New Corporate Website http://www.streetinsider.com/Globe+Newswire/Auris+Medical+Announces+Launch+of+New+Corporate+Website/18686243.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Auris+Medical+Announces+Launch+of+New+Corporate+Website/18686243.html for the full story. http://www.streetinsider.com/Globe+Newswire/Auris+Medical+Announces+Launch+of+New+Corporate+Website/18686243.html Fri, 16 Jul 2021 09:00:00 -0400 EARS Auris Medical Holding (EARS) Publication of Data from Preclinical Studies with Bentrio™ Nasal Spray in Prevention and Mitigation of SARS-CoV-2 http://www.streetinsider.com/Corporate+News/Auris+Medical+Holding+%28EARS%29+Publication+of+Data+from+Preclinical+Studies+with+Bentrio%E2%84%A2+Nasal+Spray+in+Prevention+and+Mitigation+of+SARS-CoV-2/18676201.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Auris+Medical+Holding+%28EARS%29+Publication+of+Data+from+Preclinical+Studies+with+Bentrio%E2%84%A2+Nasal+Spray+in+Prevention+and+Mitigation+of+SARS-CoV-2/18676201.html for the full story. http://www.streetinsider.com/Corporate+News/Auris+Medical+Holding+%28EARS%29+Publication+of+Data+from+Preclinical+Studies+with+Bentrio%E2%84%A2+Nasal+Spray+in+Prevention+and+Mitigation+of+SARS-CoV-2/18676201.html Wed, 14 Jul 2021 09:03:07 -0400 EARS Auris Medical Holding (EARS) Publication of Data from Preclinical Studies with Bentrio™ Nasal Spray in Prevention and Mitigation of SARS-CoV-2 http://www.streetinsider.com/FDA/Auris+Medical+Holding+%28EARS%29+Publication+of+Data+from+Preclinical+Studies+with+Bentrio%E2%84%A2+Nasal+Spray+in+Prevention+and+Mitigation+of+SARS-CoV-2/18676201.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/Auris+Medical+Holding+%28EARS%29+Publication+of+Data+from+Preclinical+Studies+with+Bentrio%E2%84%A2+Nasal+Spray+in+Prevention+and+Mitigation+of+SARS-CoV-2/18676201.html for the full story. http://www.streetinsider.com/FDA/Auris+Medical+Holding+%28EARS%29+Publication+of+Data+from+Preclinical+Studies+with+Bentrio%E2%84%A2+Nasal+Spray+in+Prevention+and+Mitigation+of+SARS-CoV-2/18676201.html Wed, 14 Jul 2021 09:03:07 -0400 EARS Auris Medical Announces Publication of Data from Preclinical Studies with Bentrio™ Nasal Spray in Prevention and Mitigation of SARS-CoV-2 http://www.streetinsider.com/Press+Releases/Auris+Medical+Announces+Publication+of+Data+from+Preclinical+Studies+with+Bentrio%E2%84%A2+Nasal+Spray+in+Prevention+and+Mitigation+of+SARS-CoV-2/18675964.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Auris+Medical+Announces+Publication+of+Data+from+Preclinical+Studies+with+Bentrio%E2%84%A2+Nasal+Spray+in+Prevention+and+Mitigation+of+SARS-CoV-2/18675964.html for the full story. http://www.streetinsider.com/Press+Releases/Auris+Medical+Announces+Publication+of+Data+from+Preclinical+Studies+with+Bentrio%E2%84%A2+Nasal+Spray+in+Prevention+and+Mitigation+of+SARS-CoV-2/18675964.html Wed, 14 Jul 2021 09:00:00 -0400 EARS Auris Medical Announces Publication of Data from Preclinical Studies with Bentrio™ Nasal Spray in Prevention and Mitigation of SARS-CoV-2 http://www.streetinsider.com/Globe+Newswire/Auris+Medical+Announces+Publication+of+Data+from+Preclinical+Studies+with+Bentrio%E2%84%A2+Nasal+Spray+in+Prevention+and+Mitigation+of+SARS-CoV-2/18675964.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Auris+Medical+Announces+Publication+of+Data+from+Preclinical+Studies+with+Bentrio%E2%84%A2+Nasal+Spray+in+Prevention+and+Mitigation+of+SARS-CoV-2/18675964.html for the full story. http://www.streetinsider.com/Globe+Newswire/Auris+Medical+Announces+Publication+of+Data+from+Preclinical+Studies+with+Bentrio%E2%84%A2+Nasal+Spray+in+Prevention+and+Mitigation+of+SARS-CoV-2/18675964.html Wed, 14 Jul 2021 09:00:00 -0400 EARS Auris Medical Holding (EARS) to Develop KRAS-Targeting RNA Treatment for Colorectal Cancer as First Therapeutic Indication for OligoPhore Technology http://www.streetinsider.com/Corporate+News/Auris+Medical+Holding+%28EARS%29+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore+Technology/18644770.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Auris+Medical+Holding+%28EARS%29+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore+Technology/18644770.html for the full story. http://www.streetinsider.com/Corporate+News/Auris+Medical+Holding+%28EARS%29+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore+Technology/18644770.html Tue, 06 Jul 2021 09:02:52 -0400 EARS Auris Medical to Develop KRAS-Targeting RNA Treatment for Colorectal Cancer as First Therapeutic Indication for OligoPhore™ Technology http://www.streetinsider.com/Press+Releases/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html for the full story. http://www.streetinsider.com/Press+Releases/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html Tue, 06 Jul 2021 09:00:00 -0400 A.37036683 A.41792313 A.60001765 EARS Auris Medical to Develop KRAS-Targeting RNA Treatment for Colorectal Cancer as First Therapeutic Indication for OligoPhore™ Technology http://www.streetinsider.com/Globe+Newswire/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html for the full story. http://www.streetinsider.com/Globe+Newswire/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html Tue, 06 Jul 2021 09:00:00 -0400 A.37036683 A.41792313 A.60001765 EARS Auris Medical to Develop KRAS-Targeting RNA Treatment for Colorectal Cancer as First Therapeutic Indication for OligoPhore™ Technology http://www.streetinsider.com/Press+Releases/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html for the full story. http://www.streetinsider.com/Press+Releases/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html Tue, 06 Jul 2021 09:00:00 -0400 A.37036683 A.41792313 A.60001765 EARS Auris Medical to Develop KRAS-Targeting RNA Treatment for Colorectal Cancer as First Therapeutic Indication for OligoPhore™ Technology http://www.streetinsider.com/Globe+Newswire/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html for the full story. http://www.streetinsider.com/Globe+Newswire/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html Tue, 06 Jul 2021 09:00:00 -0400 A.37036683 A.41792313 A.60001765 EARS Auris Medical to Develop KRAS-Targeting RNA Treatment for Colorectal Cancer as First Therapeutic Indication for OligoPhore™ Technology http://www.streetinsider.com/Press+Releases/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html for the full story. http://www.streetinsider.com/Press+Releases/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html Tue, 06 Jul 2021 09:00:00 -0400 A.37036683 A.41792313 A.60001765 EARS Auris Medical to Develop KRAS-Targeting RNA Treatment for Colorectal Cancer as First Therapeutic Indication for OligoPhore™ Technology http://www.streetinsider.com/Globe+Newswire/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html for the full story. http://www.streetinsider.com/Globe+Newswire/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html Tue, 06 Jul 2021 09:00:00 -0400 A.37036683 A.41792313 A.60001765 EARS Auris Medical to Develop KRAS-Targeting RNA Treatment for Colorectal Cancer as First Therapeutic Indication for OligoPhore™ Technology http://www.streetinsider.com/Press+Releases/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html for the full story. http://www.streetinsider.com/Press+Releases/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html Tue, 06 Jul 2021 09:00:00 -0400 A.37036683 A.41792313 A.60001765 EARS Auris Medical to Develop KRAS-Targeting RNA Treatment for Colorectal Cancer as First Therapeutic Indication for OligoPhore™ Technology http://www.streetinsider.com/Globe+Newswire/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html for the full story. http://www.streetinsider.com/Globe+Newswire/Auris+Medical+to+Develop+KRAS-Targeting+RNA+Treatment+for+Colorectal+Cancer+as+First+Therapeutic+Indication+for+OligoPhore%E2%84%A2+Technology/18644661.html Tue, 06 Jul 2021 09:00:00 -0400 A.37036683 A.41792313 A.60001765 EARS Auris Medical to Initiate Market Launch of Bentrio™ Nasal Spray in Germany http://www.streetinsider.com/Press+Releases/Auris+Medical+to+Initiate+Market+Launch+of+Bentrio%E2%84%A2+Nasal+Spray+in+Germany/18610791.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Auris+Medical+to+Initiate+Market+Launch+of+Bentrio%E2%84%A2+Nasal+Spray+in+Germany/18610791.html for the full story. http://www.streetinsider.com/Press+Releases/Auris+Medical+to+Initiate+Market+Launch+of+Bentrio%E2%84%A2+Nasal+Spray+in+Germany/18610791.html Mon, 28 Jun 2021 08:30:00 -0400 EARS Auris Medical to Initiate Market Launch of Bentrio™ Nasal Spray in Germany http://www.streetinsider.com/Globe+Newswire/Auris+Medical+to+Initiate+Market+Launch+of+Bentrio%E2%84%A2+Nasal+Spray+in+Germany/18610791.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Auris+Medical+to+Initiate+Market+Launch+of+Bentrio%E2%84%A2+Nasal+Spray+in+Germany/18610791.html for the full story. http://www.streetinsider.com/Globe+Newswire/Auris+Medical+to+Initiate+Market+Launch+of+Bentrio%E2%84%A2+Nasal+Spray+in+Germany/18610791.html Mon, 28 Jun 2021 08:30:00 -0400 EARS Auris Medical Holding (EARS) Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adult T-Cell Leukemia / Lymphoma http://www.streetinsider.com/Corporate+News/Auris+Medical+Holding+%28EARS%29+Announces+Significant+Inhibition+of+Tumor+Growth+with+OligoPhore+siRNA+Targeting+NF-%CE%BAB+in+Murine+Model+of+Adult+T-Cell+Leukemia++Lymphoma/18580947.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Auris+Medical+Holding+%28EARS%29+Announces+Significant+Inhibition+of+Tumor+Growth+with+OligoPhore+siRNA+Targeting+NF-%CE%BAB+in+Murine+Model+of+Adult+T-Cell+Leukemia++Lymphoma/18580947.html for the full story. http://www.streetinsider.com/Corporate+News/Auris+Medical+Holding+%28EARS%29+Announces+Significant+Inhibition+of+Tumor+Growth+with+OligoPhore+siRNA+Targeting+NF-%CE%BAB+in+Murine+Model+of+Adult+T-Cell+Leukemia++Lymphoma/18580947.html Mon, 21 Jun 2021 08:33:58 -0400 EARS Auris Medical Holding (EARS) Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adult T-Cell Leukemia / Lymphoma http://www.streetinsider.com/FDA/Auris+Medical+Holding+%28EARS%29+Announces+Significant+Inhibition+of+Tumor+Growth+with+OligoPhore+siRNA+Targeting+NF-%CE%BAB+in+Murine+Model+of+Adult+T-Cell+Leukemia++Lymphoma/18580947.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/Auris+Medical+Holding+%28EARS%29+Announces+Significant+Inhibition+of+Tumor+Growth+with+OligoPhore+siRNA+Targeting+NF-%CE%BAB+in+Murine+Model+of+Adult+T-Cell+Leukemia++Lymphoma/18580947.html for the full story. http://www.streetinsider.com/FDA/Auris+Medical+Holding+%28EARS%29+Announces+Significant+Inhibition+of+Tumor+Growth+with+OligoPhore+siRNA+Targeting+NF-%CE%BAB+in+Murine+Model+of+Adult+T-Cell+Leukemia++Lymphoma/18580947.html Mon, 21 Jun 2021 08:33:58 -0400 EARS Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adult T-Cell Leukemia / Lymphoma http://www.streetinsider.com/Press+Releases/Auris+Medical+Announces+Significant+Inhibition+of+Tumor+Growth+with+OligoPhore+siRNA+Targeting+NF-%CE%BAB+in+Murine+Model+of+Adult+T-Cell+Leukemia++Lymphoma/18580885.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Auris+Medical+Announces+Significant+Inhibition+of+Tumor+Growth+with+OligoPhore+siRNA+Targeting+NF-%CE%BAB+in+Murine+Model+of+Adult+T-Cell+Leukemia++Lymphoma/18580885.html for the full story. http://www.streetinsider.com/Press+Releases/Auris+Medical+Announces+Significant+Inhibition+of+Tumor+Growth+with+OligoPhore+siRNA+Targeting+NF-%CE%BAB+in+Murine+Model+of+Adult+T-Cell+Leukemia++Lymphoma/18580885.html Mon, 21 Jun 2021 08:30:00 -0400 A.41792313 EARS Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adult T-Cell Leukemia / Lymphoma http://www.streetinsider.com/Globe+Newswire/Auris+Medical+Announces+Significant+Inhibition+of+Tumor+Growth+with+OligoPhore+siRNA+Targeting+NF-%CE%BAB+in+Murine+Model+of+Adult+T-Cell+Leukemia++Lymphoma/18580885.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Auris+Medical+Announces+Significant+Inhibition+of+Tumor+Growth+with+OligoPhore+siRNA+Targeting+NF-%CE%BAB+in+Murine+Model+of+Adult+T-Cell+Leukemia++Lymphoma/18580885.html for the full story. http://www.streetinsider.com/Globe+Newswire/Auris+Medical+Announces+Significant+Inhibition+of+Tumor+Growth+with+OligoPhore+siRNA+Targeting+NF-%CE%BAB+in+Murine+Model+of+Adult+T-Cell+Leukemia++Lymphoma/18580885.html Mon, 21 Jun 2021 08:30:00 -0400 A.41792313 EARS Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adult T-Cell Leukemia / Lymphoma http://www.streetinsider.com/Press+Releases/Auris+Medical+Announces+Significant+Inhibition+of+Tumor+Growth+with+OligoPhore+siRNA+Targeting+NF-%CE%BAB+in+Murine+Model+of+Adult+T-Cell+Leukemia++Lymphoma/18580885.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Auris+Medical+Announces+Significant+Inhibition+of+Tumor+Growth+with+OligoPhore+siRNA+Targeting+NF-%CE%BAB+in+Murine+Model+of+Adult+T-Cell+Leukemia++Lymphoma/18580885.html for the full story. http://www.streetinsider.com/Press+Releases/Auris+Medical+Announces+Significant+Inhibition+of+Tumor+Growth+with+OligoPhore+siRNA+Targeting+NF-%CE%BAB+in+Murine+Model+of+Adult+T-Cell+Leukemia++Lymphoma/18580885.html Mon, 21 Jun 2021 08:30:00 -0400 A.41792313 EARS Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adult T-Cell Leukemia / Lymphoma http://www.streetinsider.com/Globe+Newswire/Auris+Medical+Announces+Significant+Inhibition+of+Tumor+Growth+with+OligoPhore+siRNA+Targeting+NF-%CE%BAB+in+Murine+Model+of+Adult+T-Cell+Leukemia++Lymphoma/18580885.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Auris+Medical+Announces+Significant+Inhibition+of+Tumor+Growth+with+OligoPhore+siRNA+Targeting+NF-%CE%BAB+in+Murine+Model+of+Adult+T-Cell+Leukemia++Lymphoma/18580885.html for the full story. http://www.streetinsider.com/Globe+Newswire/Auris+Medical+Announces+Significant+Inhibition+of+Tumor+Growth+with+OligoPhore+siRNA+Targeting+NF-%CE%BAB+in+Murine+Model+of+Adult+T-Cell+Leukemia++Lymphoma/18580885.html Mon, 21 Jun 2021 08:30:00 -0400 A.41792313 EARS